Biologics by McKesson

11/20/2025

Pancreatic cancer is one of the toughest cancers to detect and treat. There aren't a lot of symptoms at first, which means it's often diagnosed late. That's why awareness, education, and research are so important.

November 20th is World Pancreatic Cancer Day. Today, we stand with those who are working hard to change the future of this disease.

At Biologics, we support the fight against pancreatic cancer by helping to advance research and raising awareness. Together, we can foster hope and help advance the breakthroughs that will save lives.

🔗 Learn more: https://www.cancer.org/cancer/types/pancreatic-cancer.html

11/19/2025

Did you know that smoking ci******es increases the risk of at least 12 different cancers? It's the single most preventable cause of serious illness and death.

Quitting smoking can be tough. That's why the American Cancer Society's Great American Smokeout is so important. Today, November 19th, thousands of people across the U.S. will take a step toward leading healthier lives.

At Biologics, we're dedicated to getting the best treatments into the hands of the patients who need them. Sometimes, that's as simple as helping them get the support they need so they can make good choices about their health.

Find out more about the Great American Smokeout here: https://www.cancer.org/cancer/risk-prevention/tobacco/great-american-smokeout.html

11/18/2025

At Biologics, we know that a cancer diagnosis can feel like one of the darkest moments in your life. But events like Blood Cancer United's Light The Night can bring hope.

Our teams in Cary and Dallas were proud to participate with their families in this year's Light The Night events. Light The Night is an opportunity to honor those who have passed and those who are still fighting blood cancer. Attendees share their stories and offer each other support. It's also a fundraiser that has funded nearly 200 research grants and helped advance 70% of the FDA-approved blood cancer treatments available since 2017.

Thank you to everyone who came out for this year's events! We're honored to offer our support to patients, survivors, and their families.

Find out more about Light The Night: https://www.lightthenight.org/

11/17/2025

November is Gastric Cancer Awareness Month. Now is the time to focus on early detection, research, and ways to support those living with this disease.

In the U.S., about 30,300 new cases of gastric cancer (also known as stomach cancer) will be diagnosed in 2025. This kind of cancer only makes up about 1.5% of all new cancer cases, but it has a big impact—especially given how tough it can be to diagnose and treat.

Symptoms like indigestion, stomach pain, nausea, or unexplained weight loss are easy to miss. That’s why awareness and research are so important.

At Biologics, we're proud to stand with the patients, caregivers, and healthcare professionals who bring hope and healing to those with stomach cancer.

🔗 Learn more: https://www.cancer.org/cancer/types/stomach-cancer.html

11/13/2025

For many people living with NPM1-mutated acute myeloid leukemia (AML), the journey has been long and filled with setbacks. Even when treatments work at first, the disease often comes back – and sometimes, it doesn’t respond to treatment at all.

Today, there's a new reason to hope.

Biologics by McKesson is proud to be chosen by Kura Oncology as a limited specialty pharmacy provider for KOMZIFTI® (ziftomenib). This drug is the first once-daily oral menin inhibitor that targets the NPM1 mutation in adults with relapsed/refractory AML.

We're honored to help make it available to patients and support them with expert, compassionate care.

Learn more: https://biologics.mckesson.com/komzifti-ziftomenib-fda-approved-for-treatment-of-adults-with-relapsed-or-refractory-npm1-mutated-acute-myeloid-leukemia-available-at-biologics-by-mckesson/

11/13/2025

Did you know that today is NET Cancer Day? About 12,000 people in the U.S. are diagnosed with these tumors every year. They're considered rare, but as technology improves, we're able to spot them and start treating them more quickly. They often show up in the lungs, small intestines, and pancreas.

NETs, or neuroendocrine tumors, are a type of cancer that starts in cells that help control how our bodies work. They can be tough to diagnose because the symptoms are common with other types of illnesses as well. For example, flushing, diarrhea, and abdominal pain can show up with other conditions, too. This means patients with NETs might not know their diagnosis until they've undergone a lot of testing.

NETs can behave differently for each patient. That's why we need more research to improve our ability to treat them. At Biologics, we're proud to be spreading awareness and doing what we can to make sure patients with NETs have access to the support they need.

11/11/2025

This Veteran's Day, we honor and thank all the veterans who have served our country. We're proud to work alongside the veterans on the Biologics team!

11/10/2025

We had a great time last month at the Association of Cancer Care Centers 42nd National Oncology Conference in Denver! We enjoyed three days of presentations on the future of oncology in areas like care coordination, AI and machine learning, and ways to foster human connection in cancer care.

Big thanks to everyone who stopped by our booth to chat! We were glad to get a chance to talk with you. We're looking forward to seeing you next year!

11/07/2025

We're excited to be heading to the Premier Oncology Hematology Management Society (POHMS) fall conference next week! It's a great opportunity to meet with peers and discuss important topics that can affect any oncology practice. This includes everything from new legislation to physician burnout and finding the best ways to communicate with each other and with patients.

Will you be attending POHMS? Don't forget to stop by our table to meet with our team!

11/06/2025

We’re honored to walk alongside patients navigating the complexities of cell and gene therapy (CGT). Through InspiroCare, our customizable patient hub solution in collaboration with InspiroGene by McKesson, we offer personalized, compassionate support to patients and their caregivers – helping them manage the financial strain and logistical challenges that can make access to life-changing therapies feel out of reach.

For providers, InspiroCare helps ensure coordinated treatment by streamlining communication, navigating reimbursement complexities, coordinating treatment logistics, and offering comprehensive support tailored to specific care team needs.

For biopharma partners, InspiroCare offers a scalable solution backed by McKesson’s deep CGT expertise – helping bring advanced therapies to patients while maximizing operational efficiency and providing greater visibility into the workflow.

https://www.linkedin.com/posts/mckesson_cell-and-gene-therapies-are-changing-lives-activity-7389386560225345536-z2eY/

Cell and gene therapies are changing lives, but access can be complex. InspiroGene by McKesson's new InspiroCare™ Patient Hub delivers personalized support to help patients with rare and severe diseases overcome barriers and navigate their treatment journey. Read more: https://bit.ly/49nWtWA

11/04/2025

We're excited to get started here at McKesson Accelerate! Don't forget to stop by our booth to chat with our team about how we can help patients access cutting-edge oncology treatments. See you soon!

https://www.linkedin.com/posts/mckesson_mckessonaccelerate-activity-7391226576681648128-4FK-

11/03/2025

Lung cancer is the leading cause of cancer-related deaths worldwide. It leads to more deaths each year than breast, prostate, and colon cancers combined.

November is Lung Cancer Awareness Month, and we’re shining a light on just how important awareness, education, and support can be.

Lung cancer is often tough to detect early. Symptoms like a persistent cough, chest pain, or shortness of breath may not show up right away and it’s not always clear that lung cancer is the cause.

That’s why it's so important to stay informed. We can all join the fight against lung cancer by getting routine checkups, knowing the risk factors, and supporting those living with lung cancer.

At Biologics, we stand with patients, caregivers, and healthcare professionals in the fight against lung cancer. Together, we can raise awareness, foster hope, and make a difference.

🔗 Learn more: https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer